http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003513933-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| filingDate | 2000-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003513933-A |
| titleOfInvention | Interferon gamma for asthma treatment |
| abstract | (57) [Summary]nThe present invention discloses the clinical application of interferon gamma (IFN-γ), which was the first successful treatment of bronchial asthma in humans. Clinical data clearly demonstrate that continuous administration of IFN-γ at relatively low doses can be used effectively for long-term treatment of severe bronchial asthma, especially for glucocorticoid-resistant asthma. The present invention also relates to a combination therapy for administering IFN-γ and glucocorticoid, each of which alone is ineffective or insufficient in treating asthma. |
| priorityDate | 1999-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.